In the Aug. 2 Strategic Tech Investor, we introduced you to a new hot tech stock to buy: a Silicon Valley semiconductor company that is leading the charge into ultra-high-definition (UHD) video.
And we predicted the stock – which Wall Street had yet to discover – would double in less than three years.
It only took five months.
If you didn't pull the trigger on this under-the-radar stock, don't fret: The Wall Street pros are now interested and are saying this stock could double or triple from here.
And we agree.
This microchip player's existing businesses are zooming along at 40% and 50% annual rates. And the firm just announced a pact with Internet-search giant heavyweight Google Inc. (Nasdaq: GOOG), which we'll find out more about at the massive Consumer Electronics Show (CES) opening in Las Vegas Tuesday.
There's an old adage that says you never get a second chance to make a first impression.
And there's an investing parallel: You never get a second chance to get in on a "ground-floor" profit play.
With our UHD-video semiconductor company, you're looking at an all-too-infrequent exception to that rule. We're talking here about a company that's about to become a high-tech star – one of those rare "ground-floor" profit opportunities that can become an honest-to-goodness difference-maker in your life.
And you heard about it here first.
Google "Launched" This Stock
As trade events go, it's hard to beat the impact the Consumer Electronics Show has on the U.S. high-tech sector.
This is where you're guaranteed to see a steady stream of the world's most innovative products – everything from next-generation TVs to self-driving cars to 3D printing.
Indeed, a tech firm that finds itself with a hit product at CES is a lot like an actor or actress getting their "breakout" role in Hollywood.
And the company we recommended to you back in August as one of the best stocks to buy will be unveiling a new "wearable" video camera that it co-developed with Google.
We're talking about the Santa Clara, Calif.-based Ambarella Inc. (Nasdaq: AMBA), whose video-chip technology is finding its way into security cameras, automotive cameras, and the "wearable" video cams the "extreme sports" crowd uses to record their often-breathtaking exploits.
But the deal with Google could shoot Ambarella into an even-higher orbit.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.